1921
Volume 85, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

During a cluster-randomized clinical trial for trachoma in Ethiopia, two rounds of adverse event surveillance were performed in a random sample of communities after community-wide mass azithromycin treatment. The prevalence of any reported adverse event ranged from 4.9% to 7.0% in children 1–9 years of age and from 17.0% to 18.7% in persons ≥ 10 years of age. Adverse events appeared to cluster by household and perhaps by village. Mass azithromycin distributions were well tolerated in this setting.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2011.11-0056
2011-08-01
2017-07-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/2/291.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0056&mimeType=html&fmt=ahah

References

  1. Solomon A, Zondervan M, Kuper H, Buchan J, Mabey D, Foster A, , 2006. Trachoma Control: A Guide for Programme Managers. Geneva: World Health Organization.
  2. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC, , 2004. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 351: 19621971.[Crossref]
  3. West SK, Munoz B, Mkocha H, Gaydos C, Quinn T, , 2007. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. Invest Ophthalmol Vis Sci 48: 14921497.[Crossref]
  4. Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, Cevallos V, Zhou Z, Donnellan C, Saidel M, Whitcher JP, Gaynor BD, Lietman TM, , 2004. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 292: 721725.[Crossref]
  5. Sadiq ST, Glasgow KW, Drakeley CJ, Muller O, Greenwood BM, Mabey DC, Bailey RL, , 1995. Effects of azithromycin on malariometric indices in The Gambia. Lancet 346: 881882.[Crossref]
  6. Whitty CJ, Glasgow KW, Sadiq ST, Mabey DC, Bailey R, , 1999. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. Pediatr Infect Dis J 18: 955958.[Crossref]
  7. Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, Hong KC, Stoller N, Ray KJ, Emerson P, Gaynor BD, Lietman TM, , 2009. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302: 962968.[Crossref]
  8. Zuckerman JM, , 2004. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am 18: 621649.[Crossref]
  9. House JI, Ayele B, Porco TC, Zhou Z, Hong KC, Gebre T, Ray KJ, Keenan JD, Stoller NE, Whitcher JP, Gaynor BD, Emerson PM, Lietman TM, , 2009. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet 373: 11111118.[Crossref]
  10. Sommer A, Zeger SL, , 1991. On estimating efficacy from clinical trials. Stat Med 10: 4552.[Crossref]
  11. Snijders TAB, Bosker R, , 1999. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. London: Sage Publishers.
  12. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, Johnson RB, , 1992. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 327: 921925.[Crossref]
  13. Law C, Amsden GW, , 2004. Single-dose azithromycin for respiratory tract infections. Ann Pharmacother 38: 433439.[Crossref]
  14. 2006. Physicians' Desk Reference, 60th edition. Montvale, NJ: Thomson PDR.
  15. West SK, West ES, Alemayehu W, Melese M, Munoz B, Imeru A, Worku A, Gaydos C, Meinert CL, Quinn T, , 2006. Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Arch Ophthalmol 124: 309314.[Crossref]
  16. Cochereau I, Goldschmidt P, Goepogui A, Afghani T, Delval L, Pouliquen P, Bourcier T, Robert PY, , 2007. Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial. Br J Ophthalmol 91: 667672.[Crossref]
  17. Tabbara KF, Abu-el-Asrar A, al-Omar O, Choudhury AH, al-Faisal Z, , 1996. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology 103: 842846.[Crossref]
  18. Solomon AW, Akudibillah J, Abugri P, Hagan M, Foster A, Bailey RL, Mabey DC, , 2001. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. Bull World Health Organ 79: 814.
  19. Bailey RL, Arullendran P, Whittle HC, Mabey DC, , 1993. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 342: 453456.[Crossref]
  20. Bent S, Padula A, Avins AL, , 2006. Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med 144: 257261.[Crossref]
  21. Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF, , 2002. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 35: 395402.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0056
Loading
/content/journals/10.4269/ajtmh.2011.11-0056
Loading

Data & Media loading...

  • Received : 27 Jan 2011
  • Accepted : 19 May 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error